Skip to main content

Table 2 Primary outcomes regarding blood loss

From: Combined use of intravenous and topical tranexamic acid in patients aged over 70 years old undergoing total hip arthroplasty

Variable

Combined group

(N = 60)

Single IV group

(N = 60)

Topical group

(N = 60)

p

hemoglobin drop

2.67 ± 0.42

3.28 ± 0.52

3.75 ± 0.62

< 0.05

Platelet count (109/L)

138.12 ± 55.78

134.24 ± 49.29

139.52 ± 50.90

0.30

Total blood loss (mL)

757.75 ± 188.95

892.75 ± 218.47

1015.75 ± 288.71

< 0.05

  1. The values are given as the mean and standard deviation. p values indicate a significant difference among groups